Works matching IS 05135710 AND DT 2023 AND VI 66 AND IP 4


Results: 11
    1
    2
    3
    4
    5

    Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial.

    Published in:
    Yonago Acta Medica, 2023, v. 66, n. 4, p. 422, doi. 10.33160/yam.2023.11.007
    By:
    • Kensuke Naruto;
    • Tomokazu Kawaoka;
    • Shintaro Yamasaki;
    • Masanari Kosaka;
    • Yuki Shirane;
    • Yusuke Johira;
    • Shigeki Yano;
    • Kei Amioka;
    • Yutaro Ogawa;
    • Yuki Yoshikawa;
    • Kenji Yamaoka;
    • Shinsuke Uchikawa;
    • Hatsue Fujino;
    • Atsushi Ono;
    • Yasutomo Fujii;
    • Takashi Nakahara;
    • Eisuke Murakami;
    • Daiki Miki;
    • Masataka Tsuge;
    • Shiro Oka
    Publication type:
    Article
    6
    7
    8
    9
    10
    11